Bitonti R, Bozzari I, Cerutti E, et al. [Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]. FE. 2026;27(1):21-33. doi:10.7175/fe.v27i1.1605